AKT1 and type 2 diabetes mellitus: The PI3K–Akt signaling pathway is well documented for its central role in insulin signaling and glucose homeostasis [68,69], indicating that LRGFGNPPT may exert its anti-T2D effects by modulating this critical pathway.